Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.75

-1.8%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (65)	4/3/1997 6:35:00 PM
From: Douglas	of 455

To anyone interested: I found an abstract(#348) from the 4th Conference on Retroviruses and Opportunistic Infections-1997 presented by Sonderfan(Procept), the Southern Research Institute, and MRC Collaborative Centre. The title was "Safety and In Vitro Efficacy of a Topical Microbicide Gel for the Prevention of HIV-1 Transmission." If you want to read go to: 207.78.88.28 The March 17, 1997 edition of AIDS Weekly Plus (http://www.newsfile.com/031797an.htm#A9) mentions that Procept research A.J. Sonderfan and colleagures presented data in vitro and in vivo stud...(viewing 400 of 2676 total characters). I don't have a subscription so unable to get the total article. Unfortunately they don't let you buy individual articles. Does anyone subscribe?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next